Hosted on MSN1mon
In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domainIn this study in silico docking models were employed to investigate the molecular interactions between the receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein, derived from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback